TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 117 filers reported holding TCR2 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,000 | -51.9% | 13,342 | -19.0% | 0.00% | – |
| Q4 2021 | $77,000 | -75.4% | 16,469 | -55.2% | 0.00% | – |
| Q3 2021 | $313,000 | -54.6% | 36,768 | -12.6% | 0.00% | -100.0% |
| Q2 2021 | $690,000 | -28.4% | 42,061 | -3.7% | 0.00% | 0.0% |
| Q1 2021 | $964,000 | -18.9% | 43,659 | +13.6% | 0.00% | -50.0% |
| Q4 2020 | $1,189,000 | +52.2% | 38,448 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $781,000 | +107.2% | 38,448 | +56.5% | 0.00% | 0.0% |
| Q2 2020 | $377,000 | +163.6% | 24,561 | +33.0% | 0.00% | – |
| Q1 2020 | $143,000 | -45.2% | 18,463 | +1.1% | 0.00% | – |
| Q4 2019 | $261,000 | -4.7% | 18,254 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $274,000 | +602.6% | 18,254 | +568.2% | 0.00% | – |
| Q2 2019 | $39,000 | – | 2,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |